StreetInsider.com News Articles

Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion

Thu, 04 Jun 2026 08:00:00 -0400

State-Level Reform, Growing Public Acceptance, and Expanding Market Capitalizations Signal Potential Long-Term Industry Opportunity

LAS VEGAS, NV / ACCESS Newswire / June 4, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company focused on scalable mushroom cultivation and active compound production technologies, today highlighted what it believes are significant parallels between the current psychedelic industry and the early stages of the legal cannabis market.

Over the past decade, the cannabis industry evolved from a largely prohibited market into a multi-billion-dollar global sector driven by state-level legalization, growing public acceptance, expanding medical research, and

Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion

Thu, 04 Jun 2026 08:00:00 -0400

State-Level Reform, Growing Public Acceptance, and Expanding Market Capitalizations Signal Potential Long-Term Industry Opportunity

Trump Psychedelic Executive Order Accelerates Industry Growth

Mon, 27 Apr 2026 08:00:00 -0400

Hypha Labs, Inc. (FUNI) Positioned to Lead with AI-Driven Production Technology

LAS VEGAS, NV / ACCESS Newswire / April 27, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator focused on scalable production of functional and psychoactive mushroom ingredients, today announced that it is uniquely positioned to benefit from the recent executive order signed by Donald Trump to accelerate research, development, and regulatory review of psychedelic therapies for mental health disorders.

The executive order is designed to fast-track clinical research and expand access to promising treatments including psilocybin, MDMA, and ibogaine, particularly for

Trump Psychedelic Executive Order Accelerates Industry Growth

Mon, 27 Apr 2026 08:00:00 -0400

Hypha Labs, Inc. (FUNI) Positioned to Lead with AI-Driven Production Technology

The executive order is designed to fast-track clinical research and expand access to promising treatments including psilocybin, MDMA, and ibogaine, particularly for

Hypha Labs, Inc. (OTCQB:FUNI) Announces Partnership with Mycology Resources, LLC

Thu, 09 Apr 2026 08:00:00 -0400

Companies Combine Technology, Cultivation, and Global Distribution

LAS VEGAS, NV / ACCESS Newswire / April 9, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator in the functional mushroom sector, today announced the execution of a partnership agreement with Mycology Resources, LLC, a leader in advanced mushroom cultivation, extraction, and global product distribution.

The partnership combines Hypha Labs' proprietary Mushroom Accelerator technology and MicroPearls^™ delivery system with Mycology Resources' scientific cultivation expertise, ingredient development capabilities, and international distribution network. Together, the companies will commercialize scalable mushroom-based ingredients and technologies for the rapidly expanding global

Hypha Labs, Inc. (OTCQB:FUNI) Announces Partnership with Mycology Resources, LLC

Thu, 09 Apr 2026 08:00:00 -0400

Companies Combine Technology, Cultivation, and Global Distribution

Hypha Labs launches phase II partnership with Tryptomics

Wed, 01 Oct 2025 16:51:10 -0400

Hypha Labs Inc. (OTCQB: FUNI) announced the launch of Phase II in its strategic partnership with Tryptomics, combining Hypha's patented Mushroom Accelerator platform with Tryptomics' analytical testing services and genomics capabilities.

The collaboration builds on Phase I, which established dual-track validation and scalability measures. Tryptomics implemented on-site analytical testing methods at Hypha Labs and serves as an independent validation laboratory for Certificate of Analysis verification. The partnership also involves deploying duplicate Mushroom Accelerators at Tryptomics facilities for synchronized experimentation.

Phase II introduces Tryptomics' next-generation sequencing analyses called TryptoMatics and marker-assisted breeding technology known as TryptoTyping for genetic analysis. The program targets production

Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics

Wed, 01 Oct 2025 16:50:00 -0400

LAS VEGAS, NV, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, today announced the official launch of Phase II in its strategic partnership with Tryptomics, uniting Hypha's patented Mushroom Accelerator™ platform with Tryptomics On-Site™ Science Services & their contract R&D Metabolomics Pipeline to develop Hypha Labs proprietary varieties of bioreactor-optimized species and providing the gold-standard in quality assurance testing at Hypha Labs. The collaboration accelerates R&D cycles and advances the future of at-home, pharmaceutical-grade mushroom wellness.

Phase I

Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics

Wed, 01 Oct 2025 16:50:00 -0400

Phase I

Hypha Labs partners with ATS to scale mushroom technology

Mon, 29 Sep 2025 06:00:57 -0400

Hypha Labs Inc. (OTCQB: FUNI) announced it entered an agreement with Automated Technical Services to design and build a commercial-scale version of its Mushroom Accelerator technology for nutraceutical ingredient production.

The Mushroom Accelerator reduces production time for functional mushroom compounds from months to eight days. The current system operates as a countertop unit for home and small-scale users. The partnership with ATS will enable commercial-scale ingredient production for the global functional mushroom market, which the company states is valued at $33 billion and projected to reach $49 billion by 2028.

Under the agreement, ATS will work with Hypha's research and development team

Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

Mon, 29 Sep 2025 06:00:00 -0400

LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it has entered an agreement with Automated Technical Services to design and build a commercial-scale Mushroom Accelerator. This scaled-up system will produce Hypha's proprietary mushroom-based ingredients for sale to nutraceutical manufacturers worldwide.

The Mushroom Accelerator is Hypha's breakthrough smart appliance that compresses the production of potent, functional mushroom compounds from months to just eight days. While the current countertop unit serves home and small-scale users,

Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

Mon, 29 Sep 2025 06:00:00 -0400

Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator

Mon, 11 Aug 2025 09:00:00 -0400

Simple, In-Home Eight Day Cycle Generates Significant Yields of The World's Most Popular Mushroom Strains

LAS VEGAS, NV / ACCESS Newswire / August 11, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an A.I. powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that the Company has expanded the array of functional mushroom ingredients that can be harvested at home in an eight day cycle using the most recent enhancements of its revolutionary device.

Recent breakthroughs in the Company's R&D efforts now allow for the most

Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator

Mon, 11 Aug 2025 09:00:00 -0400

Simple, In-Home Eight Day Cycle Generates Significant Yields of The World's Most Popular Mushroom Strains

Recent breakthroughs in the Company's R&D efforts now allow for the most

Hypha Labs Provides Shareholder Update

Mon, 28 Jul 2025 09:08:00 -0400

LAS VEGAS, NEVADA / ACCESS Newswire / July 28, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to provide a shareholder update from its Chief Executive Officer, Stone Douglass.

Greetings,

While we have been quiet of late we have not been idle, and I am pleased to offer this brief update for your consideration. When you are at the helm of a Company which I firmly believe will soon transform an industry there are many,

Hypha Labs Provides Shareholder Update

Mon, 28 Jul 2025 09:08:00 -0400

Greetings,

Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator

Tue, 10 Jun 2025 09:15:00 -0400

LAS VEGAS, NV / ACCESS Newswire / June 10, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of a new patent application with the United States Patent and Trade Office (USPTO) for its current suite of Artificial Intelligence (AI) powered techniques to create functional mushroom ingredients in its Mushroom Accelerator.

Hypha Labs' next-generation Mushroom Accelerator harnesses Artificial Intelligence and robust cloud connectivity to redefine how medicinal mushroom mycelium is cultivated.

Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator

Tue, 10 Jun 2025 09:15:00 -0400

Hypha Labs' next-generation Mushroom Accelerator harnesses Artificial Intelligence and robust cloud connectivity to redefine how medicinal mushroom mycelium is cultivated.

Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

Tue, 13 May 2025 09:15:00 -0400

LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.

The three additional patents that have been filed are as follows:

Mushroom Accelerator System for Mycelium Cultivation - This

Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

Tue, 13 May 2025 09:15:00 -0400

The three additional patents that have been filed are as follows:

Mushroom Accelerator System for Mycelium Cultivation - This

Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade

Thu, 01 May 2025 09:30:00 -0400

LAS VEGAS, NV / ACCESS Newswire / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the acquisition of a cutting-edge High-Performance Liquid Chromatography (HPLC) analytic machine, further enhancing our capabilities in precision measurement and analysis. In a strategic partnership with Lucidity Systems, the Company is also thrilled to announce early access to their newly released variable loop autosampler upgrade, designed to elevate the performance of its already advanced machine.

This collaboration allows Hypha Labs

Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade

Thu, 01 May 2025 09:30:00 -0400

This collaboration allows Hypha Labs

New Mexico Governor Signs Bill Allowing for Psilocybin Use

Wed, 09 Apr 2025 06:00:00 -0400

‘Medical Psilocybin Act' Provides Legal Access to Citizens for the First Time

LAS VEGAS, NV / ACCESS Newswire / April 9, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that New Mexico governor Michelle Lujan signed SB 219, the Medical Psilocybin Act, which will establish the third state-legal psilocybin access system in the United States.

The Medical Psilocybin Act will provide patients with specific qualifying conditions to obtain the psychedelic and to use it

New Mexico Governor Signs Bill Allowing for Psilocybin Use

Wed, 09 Apr 2025 06:00:00 -0400

‘Medical Psilocybin Act' Provides Legal Access to Citizens for the First Time

The Medical Psilocybin Act will provide patients with specific qualifying conditions to obtain the psychedelic and to use it

Hypha Laboratories Retains Stockhouse for International Awareness Campaign

Mon, 17 Mar 2025 09:15:00 -0400

Venerable, Popular Destination to Introduce Hypha Labs to Canadian and U.S. Investors

LAS VEGAS, NV / ACCESS Newswire / March 17, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce that the Company has engaged Canada-based financial media giant Stockhouse for market awareness.

With over 1 million unique visitors a month, Stockhouse is Canada's #1 financial portal and one of North America's largest small cap investor communities. Its members are smart, affluent investors actively researching stock and